Your browser doesn't support javascript.
loading
The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction.
Aimo, Alberto; Castiglione, Vincenzo; Vergaro, Giuseppe; Panichella, Giorgia; Senni, Michele; Lombardi, Carlo Mario; Emdin, Michele.
Affiliation
  • Aimo A; Institute of Life Sciences, Scuola Superiore Sant'Anna, Piazza Martiri della Libertà 33, Pisa, Italy. a.aimo@santannapisa.it.
  • Castiglione V; Cardiology Division, Fondazione Toscana Gabriele Monasterio, Piazza Martiri della Libertà 33, Pisa, Italy. a.aimo@santannapisa.it.
  • Vergaro G; Institute of Life Sciences, Scuola Superiore Sant'Anna, Piazza Martiri della Libertà 33, Pisa, Italy.
  • Panichella G; Institute of Life Sciences, Scuola Superiore Sant'Anna, Piazza Martiri della Libertà 33, Pisa, Italy.
  • Senni M; Cardiology Division, Fondazione Toscana Gabriele Monasterio, Piazza Martiri della Libertà 33, Pisa, Italy.
  • Lombardi CM; Institute of Life Sciences, Scuola Superiore Sant'Anna, Piazza Martiri della Libertà 33, Pisa, Italy.
  • Emdin M; Cardiovascular Department & Cardiology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
Heart Fail Rev ; 27(4): 1165-1171, 2022 07.
Article in En | MEDLINE | ID: mdl-34291399
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Heart Failure / Heterocyclic Compounds, 2-Ring Limits: Humans Language: En Journal: Heart Fail Rev Journal subject: CARDIOLOGIA Year: 2022 Type: Article Affiliation country: Italy
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Heart Failure / Heterocyclic Compounds, 2-Ring Limits: Humans Language: En Journal: Heart Fail Rev Journal subject: CARDIOLOGIA Year: 2022 Type: Article Affiliation country: Italy